Milestone Pharmaceuticals

About:

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

Website: http://www.milestonepharma.com

Twitter/X: milestonepharma

Top Investors: Fonds de solidarité FTQ, BDC Venture Capital, Inovia Capital, RTW Investments, Novo Holdings

Description:

Milestone Pharmaceuticals is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone's lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.

Total Funding Amount:

$323M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2005-01-01

Contact Email:

info(AT)milestonepharma.com

Founders:

Philippe Douville

Number of Employees:

11-50

Last Funding Date:

2024-02-09

IPO Status:

Public

© 2025 bioDAO.ai